Hospital
UPMC Northwest
UPMC Northwest was paid $5.33M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoUPMC NORTHWEST
SENECA, PA 16346
SENECA, PA 16346
33aNPI1619069440assigned 09/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.33M
24GClaims234,142
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#56 of 154
Median peer was paid$2.82M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 226 | $11K | |
| 2019 | 309 | $10K | |
| 2020 | 21,230 | $428K | |
| 2021 | 101,258 | $2.34M | |
| 2022 | 35,296 | $833K | |
| 2023 | 39,687 | $867K | |
| 2024incomplete | 36,136 | $842K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 15,501 | 15,013 | $1.65M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 9,864 | 9,598 | $710K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 2,788 | 2,654 | $393K |
| G0378 | Hospital observation service, per hour | 4.3% | 973 | 414 | $230K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 3.5% | 6,981 | 5,671 | $185K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.3% | 5,135 | 4,877 | $120K |
| 80053 | Comprehensive metabolic panel | 2.1% | 11,698 | 9,723 | $113K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.9% | 708 | 686 | $100K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 19,813 | 17,150 | $99K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.6% | 1,128 | 674 | $88K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 984 | 971 | $81K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 2,192 | 1,225 | $65K |
241 more codes
| 80050 | General health panel | 1.2% | 1,359 | $63K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 1,099 | $57K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 724 | $52K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,102 | $45K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,422 | $42K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,350 | $41K |
| 80061 | Lipid panel | <1% | 3,046 | $40K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 549 | $38K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 473 | $37K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 745 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,372 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,571 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,102 | $28K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 179 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,815 | $28K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 150 | $27K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 827 | $25K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,013 | $25K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 991 | $23K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 411 | $22K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 133 | $21K |
| 82728 | <1% | 2,049 | $21K | |
| 84484 | <1% | 2,923 | $21K | |
| 71250 | <1% | 302 | $16K | |
| 83735 | <1% | 3,186 | $16K | |
| 83540 | <1% | 2,130 | $16K | |
| 82607 | <1% | 1,952 | $15K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 601 | $14K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 489 | $14K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 243 | $13K |
| 93971 | <1% | 228 | $13K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,323 | $13K |
| 72141 | <1% | 67 | $13K | |
| J3490 | Unclassified drugs | <1% | 3,615 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,118 | $13K |
| 81001 | <1% | 5,134 | $13K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 292 | $13K |
| 80076 | <1% | 1,511 | $13K | |
| 86803 | <1% | 647 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,763 | $12K |
| 96367 | <1% | 560 | $12K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 14 | $12K |
| 83690 | <1% | 3,010 | $12K | |
| 87653 | <1% | 261 | $11K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 180 | $11K |
| 84439 | <1% | 1,428 | $10K | |
| 87088 | <1% | 1,442 | $10K | |
| 82746 | <1% | 1,578 | $10K | |
| 87480 | <1% | 383 | $10K | |
| 87660 | <1% | 383 | $10K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 245 | $9K |
| 83880 | <1% | 413 | $9K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 178 | $9K |
| 86780 | <1% | 575 | $9K | |
| 83550 | <1% | 2,058 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 440 | $9K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,498 | $9K |
| 84702 | <1% | 505 | $8K | |
| 72100 | <1% | 632 | $8K | |
| 86618 | <1% | 371 | $8K | |
| 94729 | <1% | 305 | $8K | |
| 77065 | Tomosynthesis, mammo | <1% | 133 | $8K |
| 70486 | <1% | 126 | $7K | |
| 76642 | <1% | 193 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 423 | $6K |
| 84153 | <1% | 294 | $6K | |
| 72110 | <1% | 334 | $6K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 63 | $6K |
| 77066 | Tomosynthesis, mammo | <1% | 70 | $6K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 32 | $6K |
| 76770 | <1% | 158 | $5K | |
| 87340 | <1% | 358 | $5K | |
| 73610 | <1% | 305 | $5K | |
| 87040 | <1% | 479 | $5K | |
| 86762 | <1% | 230 | $5K | |
| 95886 | <1% | 102 | $4K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 274 | $4K |
| 73630 | <1% | 400 | $4K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 17 | $4K |
| 86038 | <1% | 262 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 117 | $4K |
| 85610 | <1% | 1,352 | $4K | |
| 96415 | <1% | 191 | $4K | |
| 86850 | <1% | 498 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 108 | $4K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 729 | $4K |
| 64493 | <1% | 14 | $3K | |
| 85730 | <1% | 661 | $3K | |
| 80329 | <1% | 251 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 452 | $3K |
| 82043 | <1% | 428 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 108 | $3K |
| 73030 | <1% | 253 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 1,458 | $3K |
| 83605 | <1% | 600 | $3K | |
| 73560 | <1% | 222 | $3K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $3K |
| 83970 | <1% | 75 | $3K | |
| 84703 | <1% | 299 | $3K | |
| 82570 | <1% | 400 | $3K | |
| 85652 | <1% | 991 | $3K | |
| 93017 | <1% | 101 | $2K | |
| 82950 | <1% | 358 | $2K | |
| 73130 | <1% | 246 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 58 | $2K |
| 83615 | <1% | 397 | $2K | |
| 73502 | <1% | 172 | $2K | |
| 76536 | <1% | 52 | $2K | |
| 86140 | <1% | 830 | $2K | |
| 59025 | Fetal non-stress test | <1% | 93 | $2K |
| 74018 | <1% | 182 | $2K | |
| 90715 | <1% | 166 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 96 | $2K |
| 74019 | <1% | 139 | $2K | |
| 85379 | <1% | 253 | $2K | |
| 86901 | <1% | 524 | $2K | |
| 86900 | <1% | 530 | $2K | |
| 86003 | <1% | 14 | $2K | |
| 81025 | <1% | 658 | $2K | |
| 93226 | <1% | 71 | $2K | |
| 87481 | <1% | 121 | $2K | |
| 85027 | <1% | 422 | $2K | |
| 84550 | <1% | 307 | $2K | |
| 93041 | <1% | 511 | $2K | |
| 72052 | <1% | 59 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,238 | $2K |
| 73110 | <1% | 174 | $2K | |
| 94060 | <1% | 179 | $2K | |
| 87081 | <1% | 309 | $2K | |
| 73562 | <1% | 111 | $2K | |
| 82565 | <1% | 288 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 37 | $1K |
| 87070 | <1% | 237 | $1K | |
| 82962 | <1% | 937 | $1K | |
| 84100 | <1% | 282 | $1K | |
| 84156 | <1% | 304 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,005 | $1K |
| 86431 | <1% | 156 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 106 | $1K |
| 84460 | <1% | 199 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 231 | $1K |
| 71271 | <1% | 14 | $1K | |
| 86617 | <1% | 28 | $1K | |
| 84450 | <1% | 178 | $1K | |
| 87205 | <1% | 270 | $996.57 | |
| 82784 | <1% | 43 | $989.93 | |
| 73590 | <1% | 71 | $926.28 | |
| 83721 | <1% | 78 | $912.85 | |
| 86255 | <1% | 39 | $910.50 | |
| 84403 | <1% | 35 | $893.70 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 35 | $807.31 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,748 | $806.13 |
| 93225 | <1% | 71 | $796.78 | |
| 84520 | <1% | 172 | $770.73 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,531 | $726.85 |
| 87077 | <1% | 108 | $708.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,044 | $678.91 |
| 93271 | <1% | 14 | $669.70 | |
| 93922 | <1% | 30 | $663.96 | |
| 87186 | <1% | 94 | $651.99 | |
| 84425 | <1% | 93 | $644.67 | |
| 76830 | Ultrasound, transvaginal | <1% | 16 | $600.83 |
| 82947 | <1% | 144 | $560.47 | |
| 72072 | <1% | 28 | $522.93 | |
| 76870 | <1% | 12 | $512.35 | |
| 80164 | <1% | 30 | $508.94 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,358 | $505.83 |
| 82977 | <1% | 64 | $498.49 | |
| 86922 | <1% | 14 | $493.50 | |
| 94726 | <1% | 13 | $438.53 | |
| 81003 | <1% | 174 | $435.65 | |
| 86160 | <1% | 14 | $420.03 | |
| 94760 | <1% | 260 | $415.84 | |
| 86235 | <1% | 12 | $412.47 | |
| 84146 | <1% | 18 | $403.92 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,378 | $380.37 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 869 | $372.21 |
| 86334 | <1% | 17 | $347.20 | |
| 82248 | <1% | 48 | $344.65 | |
| 82550 | <1% | 55 | $327.52 | |
| 73080 | <1% | 40 | $327.08 | |
| 82310 | <1% | 96 | $311.47 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 257 | $306.12 |
| 83655 | <1% | 27 | $293.30 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 75 | $273.11 |
| 83001 | <1% | 15 | $256.03 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,139 | $244.71 |
| 72040 | <1% | 26 | $220.99 | |
| 95819 | <1% | 26 | $218.84 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,885 | $211.57 |
| 83002 | <1% | 13 | $211.31 | |
| 76641 | <1% | 13 | $187.89 | |
| C9399 | Unclassified drugs or biologicals | <1% | 43 | $173.15 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 149 | $167.57 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,089 | $162.63 |
| 88112 | <1% | 12 | $159.46 | |
| 86039 | <1% | 14 | $155.86 | |
| 82140 | <1% | 48 | $138.42 | |
| 86706 | <1% | 12 | $137.28 | |
| 84165 | <1% | 14 | $133.57 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 319 | $130.25 |
| 73090 | <1% | 14 | $127.65 | |
| 93270 | <1% | 14 | $127.51 | |
| 82533 | <1% | 12 | $120.00 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 51 | $107.30 |
| 83986 | <1% | 57 | $102.18 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 240 | $92.61 |
| 81002 | <1% | 25 | $85.92 | |
| 88304 | <1% | 43 | $78.72 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,374 | $74.66 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 44 | $68.35 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 72 | $65.44 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 448 | $44.51 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 545 | $37.50 |
| 82009 | <1% | 16 | $31.95 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 884 | $27.04 |
| 85014 | <1% | 18 | $22.21 | |
| 85018 | <1% | 18 | $22.21 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 26 | $19.80 |
| J2704 | Injection, propofol, 10 mg | <1% | 453 | $17.70 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 743 | $13.22 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 488 | $9.84 |
| 88300 | <1% | 12 | $7.05 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,168 | $2.07 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,334 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 160 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 27 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 18 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 76 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 28 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 33 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 20 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 933 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 35 | $0.00 |
| 84311 | 0% | 40 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 127 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 48 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 46 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 38 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDINGER, BRAD (CFO)
| Provider | Location | Paid |
|---|---|---|
| UPMC Hamot | Erie, PA | $18.06M |
| UPMC Kane | Kane, PA | $1.09M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.